Deanna L. Kirkpatrick

Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $108.6 million initial public offering of 6,785,000 shares of common…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.250% U.S. dollar bonds due 2019 issued by Export Development Canada. Export…

Davis Polk advised underwriters in connection with the offering of C$750 million aggregate principal amount of 1.95% bonds due January 27, 2023, issued by the Province of Ontario. The net…

Davis Polk advised the underwriters in connection with the offering of $2.5 billion aggregate principal amount of 1.625% bonds due January 18, 2019, issued by the Province of Ontario. The…

Davis Polk advised the joint book-running managers of an SEC-registered offering by Black Hills Corporation of $250 million aggregate principal amount of its 2.500% notes due 2019 and $300…

Davis Polk advised the underwriters in connection with the offering of $300 million aggregate principal amount of 1.250% U.S. dollar bonds due 2018 issued by Export Development Canada…

Davis Polk advised underwriters in connection with the offering of $1 billion aggregate principal amount of 1.000% U.S. dollar bonds due 2018 issued by Export Development Canada. Export…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.750% U.S. dollar bonds due 2020 issued by Export Development Canada.  …

Davis Polk advised the sole structuring advisor and sole bookrunner in a Rule 144A offering by Impax Laboratories, Inc. of its 2.00% convertible senior notes due 2022. In addition,…

Davis Polk advised the underwriters in connection with the $72.5 million U.S. initial public offering of 5,175,000 common shares of Cynapsus Therapeutics Inc., including 675,000 common…